Exagen Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:XGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -10.67 M-2.88 M2.94 M-3.01 M-10.42 M -13.37 M Cash from investing activities -107 K-209 K-275 K-35 K-228 K -747 K Cash from financing activities -64 K21.93 M2.95 M-384 K-62 K 24.44 M Free cash flow -10.67 M-2.88 M2.94 M-3.01 M-10.42 M -13.37 M

News

How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%

Exagen Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-05-12

Exagen Inc. (XGN) Q1 2026 Earnings Call Transcript

Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates

AtriCure (ATRC) Reports Break-Even Earnings for Q1

Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates

KeyBanc cuts Exagen stock price target on pricing headwinds

Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11

Exagen stock price target lowered to $10 by Canaccord on margin outlook

BTIG cuts Exagen stock price target to $9 on lower revenue outlook

Exagen stock maintains Outperform rating at William Blair

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates